Science Explorer Back to mapMap
Discussion

Heron Therapeutics (United States)

In research, Heron Therapeutics (United States) stands highest in Life Sciences (#1,887 of 11,023 worldwide), Biochemistry, Genetics and Molecular Biology (#1,264 of 5,801 worldwide) and Molecular Biology (#1,039 of 3,729 worldwide), over all time.

World rank, all time
#8,702
of 34,923
Rank in United States
#1,792
of 7,310
Research works
882
▲ 80% vs 2018-21
Citations
444
0.5 per fractional work
Top-10% rate
5.8%
all institutions 10.0%
vs its own fields
1.03×
1.00× is exactly expected
Open access
3%
world 40%
International
95%
world 18%

What is Heron Therapeutics (United States) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Life SciencesDomain #1,887 of 11,023 0.2%504
Biochemistry, Genetics and Molecular BiologyField #1,264 of 5,801 0.1%444
Molecular BiologySubfield #1,039 of 3,729 0.2%308
BiomaterialsSubfield #325 of 753 0.0%241
Materials ScienceField #2,582 of 3,771 0.0%241
Physical SciencesDomain #12,396 of 17,446 0.1%269

Each strip is that field's whole ranked pool, with the notch where Heron Therapeutics (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Heron Therapeutics (United States) work in?

In 2022-now, 47% of research at Heron Therapeutics (United States) is in Health Sciences, 29% in Life Sciences. Its largest fields are Health Professions (25%), Medicine (22%), Biochemistry, Genetics and Molecular Biology (19%). It does 1.6× the world's share of Health Sciences.

Health Sciences: 10 fractional works · 46.9% of its workHealth Professions: 6 fractional works · 25.2% of its workGeneral Health Professions: 5 fractional works · 21.4% of its workSpeech and Hearing: 0 fractional works · 2.3% of its workPharmacy: 0 fractional works · 1.5% of its workMedicine: 5 fractional works · 21.6% of its workPhysiology: 1 fractional works · 5.7% of its workOncology: 1 fractional works · 4.2% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 3.2% of its workPsychiatry and Mental health: 0 fractional works · 1.9% of its workEpidemiology: 0 fractional works · 1.7% of its workGastroenterology: 0 fractional works · 1.5% of its workSurgery: 0 fractional works · 1.1% of its workInfectious Diseases: 0 fractional works · 0.7% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.6% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.4% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.3% of its workLife Sciences: 6 fractional works · 28.7% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 19.3% of its workMolecular Biology: 2 fractional works · 9.3% of its workGenetics: 1 fractional works · 5.7% of its workBiotechnology: 1 fractional works · 3.1% of its workCell Biology: 0 fractional works · 1.0% of its workPhysiology: 0 fractional works · 0.3% of its workImmunology and Microbiology: 2 fractional works · 6.9% of its workImmunology: 2 fractional works · 6.9% of its workNeuroscience: 1 fractional works · 2.4% of its workCellular and Molecular Neuroscience: 0 fractional works · 1.1% of its workNeurology: 0 fractional works · 0.5% of its workCognitive Neuroscience: 0 fractional works · 0.4% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.0% of its workSocial Sciences: 4 fractional works · 17.8% of its workArts and Humanities: 2 fractional works · 10.7% of its workPhilosophy: 2 fractional works · 10.7% of its workPsychology: 1 fractional works · 2.5% of its workExperimental and Cognitive Psychology: 0 fractional works · 2.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 0 fractional works · 2.3% of its workGeneral Economics, Econometrics and Finance: 0 fractional works · 2.3% of its workSocial Sciences: 0 fractional works · 2.3% of its workPolitical Science and International Relations: 0 fractional works · 2.3% of its workPhysical Sciences: 1 fractional works · 6.7% of its workEnvironmental Science: 1 fractional works · 4.7% of its workEcology: 1 fractional works · 3.2% of its workEnvironmental Engineering: 0 fractional works · 0.8% of its workNature and Landscape Conservation: 0 fractional works · 0.5% of its workGlobal and Planetary Change: 0 fractional works · 0.3% of its workEngineering: 0 fractional works · 2.0% of its workControl and Systems Engineering: 0 fractional works · 1.5% of its workBiomedical Engineering: 0 fractional works · 0.5% of its workALL ITS WORKHeronTherapeutics…22fractional works, 2022-now
Life Sciences29%Physical Sciences7%Health Sciences47%Social Sciences18%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 11 fields, with their numbers
    1. Health Professions625.2%
    2. Medicine521.6%
    1. Biochemistry, Genetics and Molecular Biology419.3%
    2. Immunology and Microbiology26.9%
    3. Neuroscience12.4%
    1. Arts and Humanities210.7%
    2. Psychology12.5%
    3. Economics, Econometrics and Finance02.3%
    4. Social Sciences02.3%
    1. Environmental Science14.7%
    2. Engineering02.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.62× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 6.89× its world share, 2 worksImmunology and Micro…Neuroscience: 1.49× its world share, 0 worksNeuroscienceEngineering: 0.14× its world share, 0 worksEngineeringEnvironmental Science: 0.95× its world share, 1 worksEnvironmental ScienceHealth Professions: 9.58× its world share, 6 worksHealth ProfessionsMedicine: 1.12× its world share, 5 worksMedicineArts and Humanities: 3.71× its world share, 2 worksArts and HumanitiesEconomics, Econometrics and Finance: 1.07× its world share, 0 worksEconomics, Econometr…Psychology: 0.81× its world share, 0 worksPsychologySocial Sciences: 0.18× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Health Professions, 9.6×. Every wedge is a field page.

All 11 fields, with their numbers
  1. Health Professions9.58×6 works
  2. Immunology and Microbiology6.89×2 works
  3. Arts and Humanities3.71×2 works
  4. Biochemistry, Genetics and Molecular Biology3.62×4 works
  5. Neuroscience1.49×0 works
  6. Medicine1.12×5 works
  7. Economics, Econometrics and Finance1.07×0 works
  8. Environmental Science0.95×1 works
  9. Psychology0.81×0 works
  10. Social Sciences0.18×0 works
  11. Engineering0.14×0 works

Who are the top researchers at Heron Therapeutics (United States)?

Ranked on the quality score, Barry D. Quart lead among researchers whose main affiliation is Heron Therapeutics (United States).

  1. 1 Barry D. Quart United States · #798,159 worldwide 1.6k citations · 45 works
All ranked researchers at Heron Therapeutics (United States)

What are the most cited papers from Heron Therapeutics (United States)?

The most cited paper from Heron Therapeutics (United States) is "Applying Model Based Systems Engineering (MBSE) to a standard CubeSat" (Sara Spangelo, David Kaslow, Christopher L. Delp et al., 2012), with 107 citations. Next come "Cost-Effectiveness Analyses of Natalizumab (Tysabri®) Compared with Other Disease-Modifying Therapies for People with Highly Active Relapsing-Remitting Multiple Sclerosis in the UK" (103) and "Burden of diabetic foot disorders, guidelines for management and disparities in implementation in Europe: a systematic literature review" (90).

Most cited papers
#PaperReleasedCitations
1 Applying Model Based Systems Engineering (MBSE) to a standard CubeSat Sara Spangelo, David Kaslow, Christopher L. Delp et al. Conference paper Mar 2012 107
2 Cost-Effectiveness Analyses of Natalizumab (Tysabri®) Compared with Other Disease-Modifying Therapies for People with Highly Active Relapsing-Remitting Multiple Sclerosis in the UK Ray Gani, Gavin Giovannoni, David O. Bates et al. · PharmacoEconomics 2008 103
3 Burden of diabetic foot disorders, guidelines for management and disparities in implementation in Europe: a systematic literature review Kristien Van Acker, Philippe Léger, Agnès Hartemann et al. · Diabetes/Metabolism Research and Reviews Review 27 Jan 2014 90
4 Food chain analysis of exposures and risks to wildlife at a metals-contaminated wetland Gary A. Pascoe, Richard J. Blanchet, G. Linder · Archives of Environmental Contamination and Toxicology Mar 1996 59
5 Mechanism of action of HTX-011: a novel, extended-release, dual-acting local anesthetic formulation for postoperative pain Thomas Ottoboni, Barry D. Quart, Jayne Pawasauskas et al. · Regional Anesthesia & Pain Medicine Open access 16 Dec 2019 56
All 69 most cited papers, with filters and sorting

Which keywords describe research at Heron Therapeutics (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Quality of Life, Aging, Elderly, Healthcare Legislation, Hermeneutics, Narrative, Patient Rights and Mental Health.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 15 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 15 words, with their numbers
  1. Mental Health2▲ 7.6×2 topics
  2. Quality of Life2▲ 7.7×2 topics
  3. Aging2▲ 20×1 topic
  4. Elderly2▲ 44×1 topic
  5. Healthcare Legislation2▲ 193×1 topic
  6. Hermeneutics2▲ 134×1 topic
  7. Narrative2▲ 69×1 topic
  8. Patient Rights2▲ 156×1 topic
  9. Inflammation2▲ 4.1×12 topics
  10. Cancer2▲ 6.0×8 topics
  11. Genetic Variation1▲ 23×2 topics
  12. Brown Adipose Tissue1▲ 94×1 topic
  13. Nutrigenomics1▲ 153×1 topic
  14. Personalized Nutrition1▲ 153×1 topic
  15. Thermogenesis1▲ 94×1 topic

Which research topics does Heron Therapeutics (United States) publish most on?

By volume in 2022-now: Hermeneutics and Narrative Identity, Health, Medicine and Society, Aging, Elder Care, and Social Issues and Adipose Tissue and Metabolism.

  1. 1 Hermeneutics and Narrative Identity Philosophy 2 works
  2. 2 Health, Medicine and Society General Health Professions 2 works
  3. 3 Aging, Elder Care, and Social Issues General Health Professions 2 works
  4. 4 Adipose Tissue and Metabolism Physiology 1 works
  5. 5 Nutrition, Genetics, and Disease Genetics 1 works
  6. 6 Immune cells in cancer Immunology 0 works
  7. 7 School Health and Nursing Education Speech and Hearing 0 works
  8. 8 Sleep and related disorders Experimental and Cognitive Psychology 0 works
  9. 9 Economic, financial, and policy analysis General Economics, Econometrics and Finance 0 works
  10. 10 Legal Systems and Judicial Processes Political Science and International Relations 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available3.4%not open96.6%

World: 40% of research is openly available.

with international co-authors95.1%domestic only4.9%

World: 18% is written across borders.

How has Heron Therapeutics (United States)'s research output changed?

Output in 2022-2025 was 80% higher than in 2018-2021.

still counting200020052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Heron Therapeutics (United States) as a percentage of every work published that year, 0.000040% in 2024.

still counting0.020%0.040%Heron Therapeutics (United States)0.00010% in 2025200020102020

Fractional works of Heron Therapeutics (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Redwood City

All research institutions in Redwood City

Share Heron Therapeutics (United States)'s ranking

Heron Therapeutics (United States) on Science Explorer

A card with Heron Therapeutics (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Heron Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.